| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ... Neurology 65 (12), 1863-1872, 2005 | 8913* | 2005 |
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria B Dubois, HH Feldman, C Jacova, ST DeKosky, P Barberger-Gateau, ... The Lancet Neurology 6 (8), 734-746, 2007 | 5690 | 2007 |
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3740 | 2014 |
| Mild cognitive impairment S Gauthier, B Reisberg, M Zaudig, RC Petersen, K Ritchie, K Broich, ... The lancet 367 (9518), 1262-1270, 2006 | 3702 | 2006 |
| Clinical diagnostic criteria for dementia associated with Parkinson's disease M Emre, D Aarsland, R Brown, DJ Burn, C Duyckaerts, Y Mizuno, GA Broe, ... Movement disorders: official journal of the Movement Disorder Society 22 (12 …, 2007 | 3366 | 2007 |
| Alzheimer's disease C Ballard, S Gauthier, A Corbett, C Brayne, D Aarsland, E Jones the Lancet 377 (9770), 1019-1031, 2011 | 3315 | 2011 |
| Revising the definition of Alzheimer's disease: a new lexicon B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ... The Lancet Neurology 9 (11), 1118-1127, 2010 | 2493 | 2010 |
| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2337 | 2004 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2270 | 2006 |
| Vascular cognitive impairment J T O'Brien, T Erkinjuntti, B Reisberg, G Roman, T Sawada, L Pantoni, ... The Lancet Neurology 2 (2), 89-98, 2003 | 2043 | 2003 |
| Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 1902 | 2016 |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1883 | 2016 |
| Mild cognitive impairment: a concept in evolution RC Petersen, B Caracciolo, C Brayne, S Gauthier, V Jelic, L Fratiglioni Journal of internal medicine 275 (3), 214-228, 2014 | 1876 | 2014 |
| Apolipoprotein E polymorphism and Alzheimer's disease J Poirier, P Bertrand, S Kogan, S Gauthier, J Davignon, D Bouthillier The Lancet 342 (8873), 697-699, 1993 | 1752 | 1993 |
| Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort J Jankovic, M McDermott, J Carter, S Gauthier, C Goetz, L Golbe, S Huber, ... Neurology 40 (10), 1529-1529, 1990 | 1636 | 1990 |
| Prevalence and severity of cognitive impairment with and without dementia in an elderly population JE Graham, K Rockwood, BL Beattie, R Eastwood, S Gauthier, H Tuokko, ... The Lancet 349 (9068), 1793-1796, 1997 | 1497 | 1997 |
| Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialCommentary: Another piece of the Alzheimer's jigsaw M Rösler, T Bayer, R Anand, A Cicin-Sain, S Gauthier, Y Agid, ... Bmj 318 (7184), 633-640, 1999 | 1334 | 1999 |
| Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials M Grundman, RC Petersen, SH Ferris, RG Thomas, PS Aisen, DA Bennett, ... Archives of neurology 61 (1), 59-66, 2004 | 1256 | 2004 |
| Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force B Dubois, D Burn, C Goetz, D Aarsland, RG Brown, GA Broe, D Dickson, ... Movement disorders 22 (16), 2314-2324, 2007 | 1216 | 2007 |
| Dementia with Lewy bodies I McKeith, J Mintzer, D Aarsland, D Burn, H Chiu, J Cohen-Mansfield, ... The Lancet Neurology 3 (1), 19-28, 2004 | 1123 | 2004 |
